SE8501709L - Forbettringar inom eller som henfor sig till interleukinterapi - Google Patents

Forbettringar inom eller som henfor sig till interleukinterapi

Info

Publication number
SE8501709L
SE8501709L SE8501709A SE8501709A SE8501709L SE 8501709 L SE8501709 L SE 8501709L SE 8501709 A SE8501709 A SE 8501709A SE 8501709 A SE8501709 A SE 8501709A SE 8501709 L SE8501709 L SE 8501709L
Authority
SE
Sweden
Prior art keywords
interleuk
therapy
interleukin
liposomes
sustained release
Prior art date
Application number
SE8501709A
Other languages
Unknown language ( )
English (en)
Swedish (sv)
Other versions
SE8501709D0 (sv
Inventor
T Kissel
J Reinhardt
H Schrank
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB848409127A external-priority patent/GB8409127D0/en
Priority claimed from GB848409126A external-priority patent/GB8409126D0/en
Priority claimed from GB848409128A external-priority patent/GB8409128D0/en
Priority claimed from GB848409125A external-priority patent/GB8409125D0/en
Priority claimed from GB848420381A external-priority patent/GB8420381D0/en
Priority claimed from GB848423701A external-priority patent/GB8423701D0/en
Priority claimed from GB848423700A external-priority patent/GB8423700D0/en
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of SE8501709D0 publication Critical patent/SE8501709D0/xx
Publication of SE8501709L publication Critical patent/SE8501709L/

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1277—Preparation processes; Proliposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2013—IL-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dispersion Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SE8501709A 1984-04-09 1985-04-04 Forbettringar inom eller som henfor sig till interleukinterapi SE8501709L (sv)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
GB848409127A GB8409127D0 (en) 1984-04-09 1984-04-09 Interleukin therapy
GB848409126A GB8409126D0 (en) 1984-04-09 1984-04-09 Interleukin therapy
GB848409128A GB8409128D0 (en) 1984-04-09 1984-04-09 Interleukin therapy
GB848409125A GB8409125D0 (en) 1984-04-09 1984-04-09 Interleukin therapy
GB848420381A GB8420381D0 (en) 1984-08-10 1984-08-10 Interleukin therapy
GB848423701A GB8423701D0 (en) 1984-09-19 1984-09-19 Interleukin therapy
GB848423700A GB8423700D0 (en) 1984-09-19 1984-09-19 Interleukin therapy

Publications (2)

Publication Number Publication Date
SE8501709D0 SE8501709D0 (sv) 1985-04-04
SE8501709L true SE8501709L (sv) 1985-10-10

Family

ID=27562708

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8501709A SE8501709L (sv) 1984-04-09 1985-04-04 Forbettringar inom eller som henfor sig till interleukinterapi

Country Status (13)

Country Link
US (1) US4863740A (fr)
JP (1) JPH0665650B2 (fr)
AU (1) AU4094685A (fr)
CH (1) CH668554A5 (fr)
DE (1) DE3512926A1 (fr)
DK (1) DK155085A (fr)
FR (1) FR2562421B1 (fr)
GB (1) GB2157172B (fr)
IL (1) IL74835A0 (fr)
IT (1) IT1199967B (fr)
LU (1) LU85839A1 (fr)
NL (1) NL8501010A (fr)
SE (1) SE8501709L (fr)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5059421A (en) * 1985-07-26 1991-10-22 The Liposome Company, Inc. Preparation of targeted liposome systems of a defined size distribution
EP0225130B1 (fr) * 1985-11-22 1991-10-30 Takeda Chemical Industries, Ltd. Composition de liposomes
EP0274219A3 (fr) * 1986-12-04 1988-08-03 Takeda Chemical Industries, Ltd. Composition de liposome contenant de l'interleukine-2 et méthode de sa fabrication
FR2624741B1 (fr) * 1987-12-21 1991-06-28 Pasteur Institut Compositions a base d'une combinaison de liposomes et de lymphokine presentant des proprietes immunostimulantes et leurs applications en medecine humaine et veterinaire
EP0577146A3 (fr) * 1988-05-16 1994-02-02 NeXstar Pharmaceuticals, Inc. Liposomes couplés sur des hormones
US5258499A (en) * 1988-05-16 1993-11-02 Vestar, Inc. Liposome targeting using receptor specific ligands
WO1989011270A1 (fr) * 1988-05-16 1989-11-30 Sandoz Ag Liposomes accouples a des hormones
ATE147633T1 (de) * 1988-10-27 1997-02-15 Univ Minnesota Immunhilfsmittel aus liposome enthaltend lymphokin il -2
US5234912A (en) * 1989-02-14 1993-08-10 Incyte Pharmaceuticals, Inc. Pharmaceutical compositions comprising recombinant BPI proteins and a lipid carrier and uses thereof
WO1991000289A2 (fr) * 1989-06-23 1991-01-10 The Liposome Company, Inc. Liposomes cibles et procedes d'accouplement de liposomes-proteines
JPH0363298A (ja) * 1989-07-31 1991-03-19 Green Cross Corp:The コロニー形成刺激因子・脂質複合体
US20020150539A1 (en) 1989-12-22 2002-10-17 Unger Evan C. Ultrasound imaging and treatment
US5268454A (en) * 1991-02-08 1993-12-07 La Jolla Pharmaceutical Company Composition for inducing humoral anergy to an immunogen comprising a t cell epitope-deficient analog of the immunogen conjugated to a nonimmunogenic carrier
DE4038075C1 (en) * 1990-11-29 1992-03-19 B. Braun Melsungen Ag, 3508 Melsungen, De Encapsulating solid or liq. lipophilic agents - comprises mixing hydration medium with phospholipid increasing temp. to above soln. phase change temp. and adding remaining medium
US5205290A (en) 1991-04-05 1993-04-27 Unger Evan C Low density microspheres and their use as contrast agents for computed tomography
US5817333A (en) * 1991-10-31 1998-10-06 Fujisawa Pharmaceutical Co., Ltd. Liposome preparation containing a tricyclic compound
CA2127107C (fr) * 1991-12-31 2007-06-19 Bruce L. A. Carter Methodes et compositions pour reduire les pertes sanguines
US5229109A (en) * 1992-04-14 1993-07-20 Board Of Regents, The University Of Texas System Low toxicity interleukin-2 analogues for use in immunotherapy
SI9300468A (en) * 1992-10-14 1994-06-30 Hoffmann La Roche Injectable composition for the sustained release of biologically active compounds
US5449663A (en) * 1993-06-11 1995-09-12 Bicher; Haim I. Antineoplastic compositions
US7083572B2 (en) 1993-11-30 2006-08-01 Bristol-Myers Squibb Medical Imaging, Inc. Therapeutic delivery systems
US6521211B1 (en) 1995-06-07 2003-02-18 Bristol-Myers Squibb Medical Imaging, Inc. Methods of imaging and treatment with targeted compositions
US6033645A (en) * 1996-06-19 2000-03-07 Unger; Evan C. Methods for diagnostic imaging by regulating the administration rate of a contrast agent
US6406689B1 (en) 1995-10-03 2002-06-18 Frank W. Falkenberg Compositions and methods for treatment of tumors and metastatic diseases
US7452551B1 (en) 2000-10-30 2008-11-18 Imarx Therapeutics, Inc. Targeted compositions for diagnostic and therapeutic use
US6416740B1 (en) * 1997-05-13 2002-07-09 Bristol-Myers Squibb Medical Imaging, Inc. Acoustically active drug delivery systems
EP1003531B1 (fr) 1997-05-20 2007-08-22 Ottawa Health Research Institute Procedes de preparation de constructions d'acides nucleiques
DE69829995T2 (de) * 1997-12-01 2006-02-23 Fang, Fang, San Diego Multivalente rekombinante antikörper zur behandlung von hrv infektionen
US20010003580A1 (en) * 1998-01-14 2001-06-14 Poh K. Hui Preparation of a lipid blend and a phospholipid suspension containing the lipid blend
AU756570B2 (en) * 1998-01-16 2003-01-16 Biomira Inc. Lipomatrix preparation
DE69912441T2 (de) 1998-08-19 2004-08-19 Skyepharma Canada Inc., Verdun Injizierbare wässerige propofoldispersionen
US20030035798A1 (en) 2000-08-16 2003-02-20 Fang Fang Humanized antibodies
WO2001068828A2 (fr) 2000-03-13 2001-09-20 Engene, Inc. Compositions et methodes destinees a l'expression regulee d'une proteine dans l'intestin
AU2001249389A1 (en) * 2000-03-22 2001-10-03 The Children's Hospital Of Philadelphia Modified blood clotting factors and methods of use
EP1578917A4 (fr) 2001-07-19 2008-01-23 Perlan Therapeutics Inc Proteines multimeres et methodes de production et d'utilisation de ces proteines
US20030044354A1 (en) * 2001-08-16 2003-03-06 Carpenter Alan P. Gas microsphere liposome composites for ultrasound imaging and ultrasound stimulated drug release
TWI461436B (zh) 2005-11-25 2014-11-21 Kyowa Hakko Kirin Co Ltd 人類ｃｄ１３４（ｏｘ４０）之人類單株抗體及其製造及使用方法
EP1795540A1 (fr) 2005-11-30 2007-06-13 Imaxio Complexes multiples d'antigènes et d'un adjuvant
US20070248539A1 (en) * 2006-04-24 2007-10-25 Shantha West Inc. AgRM2 antigen
EP2101813B1 (fr) 2006-11-27 2014-04-02 Patrys Limited Nouvelle cible de peptide glycosylé dans des cellules néoplasiques
JP5748653B2 (ja) 2009-04-10 2015-07-15 協和発酵キリン株式会社 抗ｔｉｍ−３抗体を用いた血液腫瘍治療法
JP5694923B2 (ja) 2009-04-27 2015-04-01 協和発酵キリン株式会社 血液腫瘍治療を目的とした抗ＩＬ−３Ｒα抗体
WO2011060233A1 (fr) 2009-11-11 2011-05-19 The Trustees Of The University Of Pennsylvania Anticorps anti-tem1 et leurs utilisations
US9783610B2 (en) 2012-04-27 2017-10-10 The Trustees Of The University Of Pennsylvania Anti-tumor endothelial marker-1 (TEM1) antibody variants and uses thereof
US9790269B2 (en) 2013-02-08 2017-10-17 Misfolding Diagnostics, Inc. Transthyretin antibodies and uses thereof
EP3013945B1 (fr) 2013-06-25 2020-05-27 Temple University Of The Commonwealth System Of Higher Education Cellules souches dérivées d'os cortical
BR112018070948A2 (pt) 2016-04-13 2019-01-29 Orimabs Ltd. anticorpos anti-psma e utilização dos mesmos
EP4585226A1 (fr) 2022-09-09 2025-07-16 Institute Of Science Tokyo Agent thérapeutique contre une infection à coronavirus

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5186117A (en) * 1975-01-27 1976-07-28 Tanabe Seiyaku Co Johoseibiryushiseizainoseiho
GB1578776A (en) * 1976-06-10 1980-11-12 Univ Illinois Hemoglobin liposome and method of making the same
US4235871A (en) * 1978-02-24 1980-11-25 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles
US4377567A (en) * 1978-10-02 1983-03-22 The Procter & Gamble Company Lipid membrane drug delivery
JPS55153713A (en) * 1979-05-02 1980-11-29 Kureha Chem Ind Co Ltd Pharmaceutical preparation of ribosome containing active substance
JPS56127308A (en) * 1980-03-11 1981-10-06 Green Cross Corp:The Blood-coagulation factor 8 pharmaceutical
DE3374837D1 (en) * 1982-02-17 1988-01-21 Ciba Geigy Ag Lipids in the aqueous phase
JPH0751511B2 (ja) * 1982-03-15 1995-06-05 味の素株式会社 インターロイキン２を含有してなる癌治療剤
AU564876B2 (en) * 1982-03-29 1987-08-27 Liposome Company, Inc., The Stable plurilamellar vesicles
US4522803A (en) * 1983-02-04 1985-06-11 The Liposome Company, Inc. Stable plurilamellar vesicles, their preparation and use
EP0109861A3 (fr) * 1982-11-23 1986-05-14 Bio-Response Inc. Procédé pour isoler des cellules
WO1985000606A1 (fr) * 1983-07-19 1985-02-14 Takeda Chemical Industries, Ltd. Il-2 humaine et son procede de preparation
US4464461A (en) * 1983-07-22 1984-08-07 Eastman Kodak Company Development of light-sensitive quinone diazide compositions
US4764359A (en) * 1984-05-25 1988-08-16 Lemelson Jerome H Drug compositions and their use in treating human or other mammalian patients
CA1260393A (fr) * 1984-10-16 1989-09-26 Lajos Tarcsay Liposomes de lipides synthetiques

Also Published As

Publication number Publication date
FR2562421A1 (fr) 1985-10-11
NL8501010A (nl) 1985-11-01
GB2157172A (en) 1985-10-23
IT1199967B (it) 1989-01-05
JPH0665650B2 (ja) 1994-08-24
IT8547939A1 (it) 1986-10-09
JPS60243022A (ja) 1985-12-03
CH668554A5 (de) 1989-01-13
GB8508809D0 (en) 1985-05-09
GB2157172B (en) 1988-12-29
IT8547939A0 (it) 1985-04-09
US4863740A (en) 1989-09-05
SE8501709D0 (sv) 1985-04-04
FR2562421B1 (fr) 1989-02-17
AU4094685A (en) 1985-10-17
IL74835A0 (en) 1985-07-31
DK155085D0 (da) 1985-04-03
DE3512926A1 (de) 1985-10-24
LU85839A1 (fr) 1985-12-16
DK155085A (da) 1985-10-10

Similar Documents

Publication Publication Date Title
SE8501709L (sv) Forbettringar inom eller som henfor sig till interleukinterapi
FI830254A0 (fi) Substituerade 9-(1 eller 3-monoacyloxi eller 1,3-diacyloxi-2-propoximetyl)puriner som antivirala aemnen
ES2022884B3 (es) Camara compuesta .
DE68909693D1 (de) Angetriebenes Atemgerät.
FI873185L (fi) Nya peptider.
FI854809A7 (fi) Branddetektor som baserar sig pao minskat ljus.
DE3782355D1 (de) Frequenzstabilisierte lichtquelle.
FI874287L (fi) Nya lymfokinpeptider.
FI884387L (fi) Nya gelkompositioner.
DE68900798D1 (de) Luftpumpe.
FI861905A0 (fi) Hydraulisk mekanism, motor eller pump, foersedd med pao kolvarna anordnade rullar och med organ foer att haolla naemnda rullar pao plats.
FI863361L (fi) Blandningar som grundar sig pao vatten-haerdbara termoplastiska polymerer och som silanolkondensationskatalysatorer verkande metallkarboxylat.
FI864516A7 (fi) Vähänvaahtoavia koostumuksia.
FI832832A7 (fi) Substituerad 9-(1-0- eller 3-0-monosubstituerad eller 1,3-d1-0-substituerad propoxymetyl)-puriner som antiviral agenter
FI880734L (fi) Nya foereningar som effektivare renin-inhibitorer.
FR2655612B1 (fr) Helicopteres combines.
DE3672140D1 (de) Polyimid - poly ( arylketon ) mischungen.
FI874014L (fi) Foerbaettringar som haenfoer sig till tryckplattor.
FR2655611B1 (fr) Helicopteres combines.
FI873397L (fi) Foerbaettringar till eller som haenfoer sig till straolningskaensliga anordningar.
DE3689171D1 (de) Wasserlösliche xanthyliumabkömmlinge.
FI860333L (fi) Utspridare foer ingaongsluft.
DE68907148D1 (de) Luftdiffusionseinheit.
FI900661A0 (fi) Nya formbara sammansaettningar som haerdas i vaerme.
FI886045A7 (fi) Nya 4-kloro -3-sulfamoylbensoesyrahydrazider, foerfarande foer deras framstaellning, dessa innehaollande farmaceutiska kompositioner och deras anvaendning som laekemedel.

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8501709-3

Effective date: 19870206